As of 2026-09-16, the Relative Valuation of WAVE Life Sciences Ltd (WVE) is (8.50) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.46 USD, the upside of WAVE Life Sciences Ltd based on Relative Valuation is -290.5%.
The range of the Relative Valuation is (3.96) - (13.68) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 2.9x - 13.0x | 8.1x |
| Forward P/E multiples | 3.8x - 13.0x | 8.0x |
| Fair Price | (3.96) - (13.68) | (8.50) |
| Upside | -188.7% - -406.7% | -290.5% |
| Date | P/E |
| 2026-09-14 | -4.35 |
| 2026-09-11 | -4.36 |
| 2026-09-10 | -4.44 |
| 2026-09-09 | -4.57 |
| 2026-09-08 | -4.67 |
| 2026-09-04 | -4.62 |
| 2026-09-03 | -4.47 |
| 2026-09-02 | -4.64 |
| 2026-09-01 | -4.72 |
| 2026-08-31 | -4.66 |
| 2026-08-28 | -4.79 |
| 2026-08-27 | -4.90 |
| 2026-08-26 | -4.97 |
| 2026-08-25 | -4.99 |
| 2026-08-24 | -4.87 |
| 2026-08-21 | -5.03 |
| 2026-08-20 | -4.99 |
| 2026-08-19 | -5.15 |
| 2026-08-18 | -5.03 |
| 2026-08-17 | -4.84 |
| 2026-08-14 | -5.14 |
| 2026-08-13 | -4.94 |
| 2026-08-12 | -4.98 |
| 2026-08-11 | -4.79 |
| 2026-08-10 | -5.77 |
| 2026-08-07 | -5.80 |
| 2026-08-06 | -5.72 |
| 2026-08-05 | -5.63 |
| 2026-08-04 | -5.70 |
| 2026-08-03 | -5.45 |
| 2026-07-31 | -5.24 |
| 2026-07-30 | -5.47 |
| 2026-07-29 | -5.52 |
| 2026-07-28 | -5.60 |
| 2026-07-27 | -5.63 |
| 2026-07-24 | -5.52 |
| 2026-07-23 | -5.49 |
| 2026-07-22 | -5.45 |
| 2026-07-21 | -5.50 |
| 2026-07-20 | -5.44 |
| 2026-07-17 | -5.53 |
| 2026-07-16 | -5.39 |
| 2026-07-15 | -5.62 |
| 2026-07-14 | -5.83 |
| 2026-07-13 | -5.65 |
| 2026-07-10 | -5.94 |
| 2026-07-09 | -6.00 |
| 2026-07-08 | -5.93 |
| 2026-07-07 | -6.06 |
| 2026-07-06 | -6.01 |